- Horizon Platform Originates $47 Million of New Loans in Q1, Including $40 Million of New Loans for HRZN -
- Horizon Platform Ends Quarter with Committed Backlog
Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's (NASDAQ: FULC) Investigational New Drug (IND) application for FTX-6058 for the potential treatment of